You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thymic Carcinoma

Showing 1 - 25 of 7,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

Recruiting
  • Thymic Carcinoma
  • Envolizumab combined with radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 3, 2023

Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Thymic Carcinoma Trial in New York (KN046)

Recruiting
  • Thymic Carcinoma
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Thymoma and Thymic Carcinoma Trial in Rozzano (Everolimus)

Completed
  • Thymoma and Thymic Carcinoma
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Molecular Analysis and Treatment Options of Thymic Malignancies

Recruiting
  • Thymic Epithelial Tumor
  • +2 more
  • Shanghai, Shanghai, China
    Xiaomin Niu
Dec 28, 2022

Thymic Carcinoma Trial in Shanghai (KN046)

Recruiting
  • Thymic Carcinoma
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
May 16, 2022

Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)

Recruiting
  • Stage III Thymoma AJCC v8
  • +6 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 11, 2022

Thymic Carcinoma Trial in Columbus (other, biological, drug)

Recruiting
  • Thymic Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Metastatic Thymic Carcinoma, Thymoma Type B3 Trial in France, Italy, Spain (Pembrolizumab, Lenvatinib 10 mg)

Recruiting
  • Metastatic Thymic Carcinoma
  • Thymoma Type B3
  • Bordeaux, France
  • +9 more
Feb 7, 2022

Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA Trial in United States (Cetuximab, Cisplatin, Doxorubicin &

Active, not recruiting
  • Thymoma
  • +2 more
  • Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
  • Duarte, California
  • +7 more
May 27, 2022

Thymoma Type B3, Thymic Carcinoma Trial in Worldwide (Nivolumab)

Recruiting
  • Thymoma Type B3
  • Thymic Carcinoma
  • Brussel, Belgium
  • +19 more
Jul 1, 2022

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Caregiver, Malignant Pleural Tumor, Metastatic Thymic Carcinoma Trial in Columbus (Palliative Therapy, Questionnaire

Completed
  • Caregiver
  • +11 more
  • Palliative Therapy
  • Questionnaire Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 11, 2022

Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

Not yet recruiting
  • Untreated Advanced or Recurrent Thymic Carcinomas
  • Chuo, Tokyo, Japan
    National Cancer Center Hospital
Apr 16, 2023

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

Recruiting
  • Type B3 Thymoma
  • Thymic Carcinoma
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)

Active, not recruiting
  • Thymoma and Thymic Carcinoma
  • Thymosin a1
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 27, 2021

Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

Not yet recruiting
  • Adrenal Cortical Carcinoma
  • +3 more
  • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
  • Shanghai, Shanghai, China
    Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
Nov 19, 2023

Thymic Carcinoma, NSCLC, Refractory Thoracic Tumors Trial in United States (VEGFR/PDGFR Dual Kinase Inhibitor X-82, Nivolumab)

Active, not recruiting
  • Thymic Carcinoma
  • +3 more
  • VEGFR/PDGFR Dual Kinase Inhibitor X-82
  • Nivolumab
  • Palo Alto, California
  • +6 more
Sep 21, 2022

Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)

Active, not recruiting
Has Results
  • Thymoma
  • Thymus Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022

Thymic Carcinoma, Thymoma Trial in Milan (Ramucirumab)

Recruiting
  • Thymic Carcinoma
  • Thymoma
  • Ramucirumab
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 12, 2020

Molecular Analysis of Thoracic Malignancies

Enrolling by invitation
  • Thymus Cancer
  • +5 more
    • Stanford, California
      Stanford University School of Medicine
    Jun 8, 2021

    NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +10 more
    • Singapore, Singapore
      Novartis Investigative Site
    Nov 16, 2022

    Thymoma and Thymic Carcinoma Trial in Xi'an (Chemotherapy+Pembrolizumab.)

    Recruiting
    • Thymoma and Thymic Carcinoma
    • Xi'an, Shaanxi, China
      Tangdu Hospital, Fourth Military Medical University
    Oct 26, 2020